Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies

Background: The elastase inhibitor α-1-antitrypsin (AAT), is a member of the serpin superfamily of protease inhibitors. AAT has a characteristic secondary structure of three-β-sheets, nine-α-helices and a reactive central loop (RCL). This protein inhibits target proteases...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sangachini,Elham Dasi, Hasannia,Sadegh, Taghdir,Majid, Pirooznia,Nazanin, Ghadicholaei,Kamran Khalili
Lenguaje:English
Publicado: Pontificia Universidad Católica de Valparaíso 2012
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582012000200008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-34582012000200008
record_format dspace
spelling oai:scielo:S0717-345820120002000082012-06-06Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studiesSangachini,Elham DasiHasannia,SadeghTaghdir,MajidPirooznia,NazaninGhadicholaei,Kamran Khalili alpha1-antitrypsin molecular dynamic simulation Pichia pastoris Background: The elastase inhibitor α-1-antitrypsin (AAT), is a member of the serpin superfamily of protease inhibitors. AAT has a characteristic secondary structure of three-β-sheets, nine-α-helices and a reactive central loop (RCL). This protein inhibits target proteases by forming a stable complex in which the cleaved RCL is inserted into β-sheet-A of the serpin, leading to a conformational change in the AAT protein. Spontaneous polymerization and instability of AAT are challenges with regard to producing drugs against AAT-deficient diseases. Therefore, the purpose of many investigations currently is to produce drugs with lower degrees of polymerization and higher stabilities. In order to investigate the effect of the N-terminal segment (residues 1-43) on AAT structure, molecular dynamic (MD) simulation was used to study structural properties including Root-mean-square deviation (RMSD), internal motions, intramolecular non-bonded interactions and the total accessible surface area (ASA) of native and reduced AAT. These properties were compared in native and truncated AAT. Results: Theoretical studies showed no noticeable differences in the dynamic and structural properties of the two structures. These findings provided the basis for the experimental phase of the study in which sequences from the two AAT constructs were inserted into the expression vector pGAPZ and transformed into Pichia pastoris. Results showed no differences in the activities and polymerization of the two AAT constructs. Conclusions: As small-scale medicines are preferred by lung drug delivery systems, in this study AAT was designed and constructed by decreasing the number of amino acids at the N-terminal region.info:eu-repo/semantics/openAccessPontificia Universidad Católica de ValparaísoElectronic Journal of Biotechnology v.15 n.2 20122012-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582012000200008en
institution Scielo Chile
collection Scielo Chile
language English
topic alpha1-antitrypsin
molecular dynamic simulation
Pichia pastoris
spellingShingle alpha1-antitrypsin
molecular dynamic simulation
Pichia pastoris
Sangachini,Elham Dasi
Hasannia,Sadegh
Taghdir,Majid
Pirooznia,Nazanin
Ghadicholaei,Kamran Khalili
Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
description Background: The elastase inhibitor α-1-antitrypsin (AAT), is a member of the serpin superfamily of protease inhibitors. AAT has a characteristic secondary structure of three-β-sheets, nine-α-helices and a reactive central loop (RCL). This protein inhibits target proteases by forming a stable complex in which the cleaved RCL is inserted into β-sheet-A of the serpin, leading to a conformational change in the AAT protein. Spontaneous polymerization and instability of AAT are challenges with regard to producing drugs against AAT-deficient diseases. Therefore, the purpose of many investigations currently is to produce drugs with lower degrees of polymerization and higher stabilities. In order to investigate the effect of the N-terminal segment (residues 1-43) on AAT structure, molecular dynamic (MD) simulation was used to study structural properties including Root-mean-square deviation (RMSD), internal motions, intramolecular non-bonded interactions and the total accessible surface area (ASA) of native and reduced AAT. These properties were compared in native and truncated AAT. Results: Theoretical studies showed no noticeable differences in the dynamic and structural properties of the two structures. These findings provided the basis for the experimental phase of the study in which sequences from the two AAT constructs were inserted into the expression vector pGAPZ and transformed into Pichia pastoris. Results showed no differences in the activities and polymerization of the two AAT constructs. Conclusions: As small-scale medicines are preferred by lung drug delivery systems, in this study AAT was designed and constructed by decreasing the number of amino acids at the N-terminal region.
author Sangachini,Elham Dasi
Hasannia,Sadegh
Taghdir,Majid
Pirooznia,Nazanin
Ghadicholaei,Kamran Khalili
author_facet Sangachini,Elham Dasi
Hasannia,Sadegh
Taghdir,Majid
Pirooznia,Nazanin
Ghadicholaei,Kamran Khalili
author_sort Sangachini,Elham Dasi
title Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
title_short Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
title_full Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
title_fullStr Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
title_full_unstemmed Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
title_sort construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
publisher Pontificia Universidad Católica de Valparaíso
publishDate 2012
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582012000200008
work_keys_str_mv AT sangachinielhamdasi constructionofanengineeredalpha1antitrypsinwithinhibitoryactivitybasedontheoreticalstudies
AT hasanniasadegh constructionofanengineeredalpha1antitrypsinwithinhibitoryactivitybasedontheoreticalstudies
AT taghdirmajid constructionofanengineeredalpha1antitrypsinwithinhibitoryactivitybasedontheoreticalstudies
AT pirooznianazanin constructionofanengineeredalpha1antitrypsinwithinhibitoryactivitybasedontheoreticalstudies
AT ghadicholaeikamrankhalili constructionofanengineeredalpha1antitrypsinwithinhibitoryactivitybasedontheoreticalstudies
_version_ 1718441853741694976